ORF_ID	CONTIG	START	STOP	ORIENTATION	CUT_OFF	PASS_EVALUE	Best_Hit_evalue	Best_Hit_ARO	Best_Identities	ARO	ARO_name	Model_type	SNP	Best_Hit_ARO_category	ARO_category	PASS_bitscore	Best_Hit_bitscore	bit_score	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	LABEL	ID	Model_id
BGC0001145.1|Cyclothiazomycin_6	ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.757	8847	9866	+	Loose	n/a	9.71085	arlR	45.83	ARO:3000838	arlR	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	410	23.8682	23.8682	ATGCCGACCGCTAGCGACCCCCTGCCGCCCGAGGAGGCCGCGGGCGCGGACTGGGTGGCCGCGCACGTCTTCTACGACACCGACCAGGACGGACTGCTGACCGGCTGCGTCCGGCCGCTGGCCGAGGAGCTGACCCGCGCCGGGCTCGTCCGGCGGTCGTTCTTCCTGCGCTACTGGGAGGGCGGACCGCATGTGCGGCTGCGCCTGCTGCCCGCCCGCCGGGCGGACCGGGCCGAGGTCGAGCGGCTGGCCGGTGAACGGATCCGCGCCCATCTGGAACGCCACCCGGCGCCCGACGTGGTGGACCGCTCCCGCTTCGAGGGGGTGGCCGCCGAACTGGCCGGCCTGGAGGGCCGTCCGGGGCACGACACGGCCGTGCGGCCCAACAACACGGTGGAGTTCCTGCCGTACGAGCGGGAGCACGAGGACTACGGGCACGGTCCCGCGATCGCCGCCGTGGAGCGGCACTTCGCCGAGTCCAGCGAGCTGGCCTTCTCGGTGGTGGCGGCGGGCACGACCGTCGAGCAGCGCGCGCTGCTGGCGTTCGACCTGGTCGTCGGGGTGTTCGCGCTGTGCGACGAGATCCGCGGCCGGTGGGCGCGGGCCGGCGGGCCGCCGCTGCCCTTCGGCAGCGGACCGGAGGCCGAGGACCTCGAACCCCGCTACCGGGCCCAGCGCGAGCCGCTGCGCGAACGGGCGCTGCGCACCTGGCGGGTCGCCGAGGAGGGTGCCGCCCGGCCGGACCAGCGGACGTACTGGCTGGACTCGGTCCGGCGGCTGCGCGACACCCTGCACGCCCTGGAGGACGCGGGCGACTTCACCACCGCCTGGGCGGACTCCCCGCTGGCCGTCCCCCTCGACCTGGCCGCCACCCGGCACCCGTCCACCAGTCTGGTGCTGCTGCGCTGCGCGCACCTCGTCAACAACCGGCTGGGGCTGACCCTGTGGCAGGAGAACCAGGTGCGGTTCCTGGTGGGCCGGGTGCTCGCCGAGCTCCCCGAAGCGCTGGCCGCCCCATGA	MPTASDPLPPEEAAGADWVAAHVFYDTDQDGLLTGCVRPLAEELTRAGLVRRSFFLRYWEGGPHVRLRLLPARRADRAEVERLAGERIRAHLERHPAPDVVDRSRFEGVAAELAGLEGRPGHDTAVRPNNTVEFLPYEREHEDYGHGPAIAAVERHFAESSELAFSVVAAGTTVEQRALLAFDLVVGVFALCDEIRGRWARAGGPPLPFGSGPEAEDLEPRYRAQREPLRERALRTWRVAEEGAARPDQRTYWLDSVRRLRDTLHALEDAGDFTTAWADSPLAVPLDLAATRHPSTSLVLLRCAHLVNNRLGLTLWQENQVRFLVGRVLAELPEALAAP	MTQILIVEDEQNLARFLELELTHENYNVDTEYDGQDGLDKALSHYYDLIILDLMLPSINGLEICRKIRQQQSTPIIIITAKSDTYDKVAGLDYGADDYIVKPFDIEELLARIRAILRRQPQKDIIDVNGITIDKNAFKVTVNGAEIELTKTEYDLLYLLAENKNHVMQREQILNHVWGYNSEVETNVVDVYIRYLRNKLKPYDRDKMIETVRGVGYVIR	BGC0001145.1|Cyclothiazomycin_6#8848#9867#1#ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.757	gnl|BL_ORD_ID|502|hsp_num:0	1390
BGC0001145.1|Cyclothiazomycin_3	ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.678	3994	4176	+	Loose	n/a	0.00441799	Escherichia coli LamB	37.14	ARO:3004126	Escherichia coli LamB	protein homolog model	n/a	gene conferring resistance via absence; protein modulating permeability to antibiotic	gene conferring resistance via absence; protein modulating permeability to antibiotic	850	30.0314	30.0314	ATGGAGGCGAAGCTCGAACTGGACCTCGGCGACCTGAGCGTCGAGGAACTCGACGTGCTGCCCACCTCGCCGGGTGCCGGCCTGGAGTCGATCAACGTCGGCCACGCCATGGTCGAGATCGGCGCGTCCAACTGCACCTCGCGCGGTACGCCCGCGAGCTGCTGCTCCTGTTGCTGCTGCTGA	MEAKLELDLGDLSVEELDVLPTSPGAGLESINVGHAMVEIGASNCTSRGTPASCCSCCCC	MMITLRKLPLAVAVAAGVMSAQAMAVDFHGYARSGIGWTGSGGEQQCFQTTGAQSKYRLGNECETYAELKLGQEVWKEGDKSFYFDTNVAYSVAQQNDWEATDPAFREANVQGKNLIEWLPGSTIWAGKRFYQRHDVHMIDFYYWDISGPGAGLENIDVGFGKLSLAATRSSEAGGSSSFASNNIYDYTNETANDVFDVRLAQMEVNPGGTLELGVDYGRANLRDNYRLVDGASKDGWLFTAEHTQSVLKGFNKFVVQYATDSMTSQGKGLSQGSGVAFDNEKFAYNINNNGHMLRILDHGAISMGDNWDMMYVGMYQDINWDNDNGTKWWTVGIRPMYKWTPIMSTVMEIGYDNVESQRTGDKNNQYKITLAQQWQAGDSIWSRPAIRVFATYAKWDEKWGYDYNGDSKVNPNYGKAVPADFNGGSFGRGDSDEWTFGAQMEIWW	BGC0001145.1|Cyclothiazomycin_3#3995#4177#1#ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.678	gnl|BL_ORD_ID|2164|hsp_num:0	2788
BGC0001145.1|Cyclothiazomycin_7	ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.765	9863	11056	+	Loose	n/a	4.61552	dfrA24	29.76	ARO:3002856, ARO:3001609	OXA-114a, dfrA24	protein homolog model	n/a	antibiotic target replacement protein; determinant of diaminopyrimidine resistance	antibiotic inactivation enzyme; antibiotic target replacement protein; determinant of beta-lactam resistance; determinant of diaminopyrimidine resistance	500	25.0238	25.0238, 24.2534	ATGAGCCGGCCGGCGCCCCGGTGGCACAGTCTCCACGTCCACCACCACGACGCGGACGCCGAGCCCGCGCTCGTCCTGGACGCCGTCCGCCCCGCGTTCGAGGCCGTGCGGCCGTGGACGCGGGGCACCTGGTTCGGCCGGCACTGGCTGCGCGGACCGCACCTGCGCCTCAACTTCCGGGCGCCCGGCCCGGTGTGGGAGGCCAGGATCCGTCCGGTGGTGACGGAGCGGATCGAGGCGTACCTGCGCGTCCGGCCGTCGCGGGTGCGGCTGGACGAGGCGGCGCTGGCGCCGGTGCACGCGCGCCTGGCCGAACTGGAGATGGAGACCGGCGCCCGGCACCCCTGGGTCCCCGACAACACGGTGCTGGAACGCCCCTACGACCACCGGCTGCCGGTCCTGGGCTCGCCGCGGGCGAGCGAGCTGCTGGCCGGATTCCTCTCCGACACCGACGACCTGGCGTTCCGGATGTACGAGCGCCGGGCGGCGGGCGGGTCGACGGCCGCGCTGGCGCTGGACCTGATGTGGACCACCGCTGCGGTGGCGGCGGTCCCGTTCGAGACCGGCGCTCCGCCGATCGTGCGCGGCTACCTGTCGCTGCGCTCGCACGCCGACGCGTTCCTGTCCCGTACGCGTGACCCGGCGGCCCATCGGGCCGCGTTCGACGCCCGGTACCACCGCCAGGCCGATGCCTTGGGCGCGCGGCTGCGCGCGGTGCAGGAGGCGGTGGACGGGCGGCGGGAGGACGTGCCGTTCGTCGCCGACTGGGCCGCCGCGATCCGCCGCCGGCAGCGGATCGCCTACCCCCAACTGGCCTCCGGCGCGGTCTCGATGCGCGGCGCCGGCCTGGCGCCGCGACCGCCGGCCCGGCAGGTGAGCGGCTTCCACCGGCTGCTCCAGTCGGGCCACGGGCAGGAGGACTTCCTCTGGACCGACCCGTGGTTCGCCTCCTTCCGCCTGGTGGTCAACTACCTCTACGTCCACCTCAACCGCCTCGGCCTGGGTCCGGCCGACCGTGCTCTCCTGTGCCACCTGGCGGCCTCCACCGTGGAGGGCGTCCACGGCGTCACCGCCACCGAGGTCTTCCGCCGCCACGTCCTCCCGCCGTCCCGGGACCAGGTCCCGGAGTGGCGGCGGCTGGCCGCCGAGTGGGGCCGGGCGGCCGGCTCGGCGCCGGCCGAGCGGCAGGGGTGA	MSRPAPRWHSLHVHHHDADAEPALVLDAVRPAFEAVRPWTRGTWFGRHWLRGPHLRLNFRAPGPVWEARIRPVVTERIEAYLRVRPSRVRLDEAALAPVHARLAELEMETGARHPWVPDNTVLERPYDHRLPVLGSPRASELLAGFLSDTDDLAFRMYERRAAGGSTAALALDLMWTTAAVAAVPFETGAPPIVRGYLSLRSHADAFLSRTRDPAAHRAAFDARYHRQADALGARLRAVQEAVDGRREDVPFVADWAAAIRRRQRIAYPQLASGAVSMRGAGLAPRPPARQVSGFHRLLQSGHGQEDFLWTDPWFASFRLVVNYLYVHLNRLGLGPADRALLCHLAASTVEGVHGVTATEVFRRHVLPPSRDQVPEWRRLAAEWGRAAGSAPAERQG	MTYQLDVSKILSFDLEAIVAATENGGIGYKGDLPWRLQGDLKRFREITQGGIVIMGAGTYKSLPSPLKDRINIVITKKSEISWTACYDVRVVNSPEDALRMVGRIIDEKEEQGRDRPRVFVIGGASIYQALMPFVSTLHWTEVHVEQLPEEIGLDTYIEDFLSLRGTSTPKRKSNLVLPPTPTTP	BGC0001145.1|Cyclothiazomycin_7#9864#11057#1#ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.765	gnl|BL_ORD_ID|2120|hsp_num:0	263
BGC0001145.1|Cyclothiazomycin_10	ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.786	12918	15725	-	Loose	n/a	0.0853867	evgA	32.61	ARO:3000826, ARO:3000832, ARO:3003942, ARO:3000596	evgA, ErmX, abcA, sdiA	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	antibiotic target modifying enzyme; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance; efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	400	31.5722	30.8018, 31.5722, 26.9498, 25.409	ATGGCGTCGGTCGGCGCGACCGGTCGGGGGAGCGAACTGGCCCGCTTGGCGGGCCTGTTCGACGAGGCTCGCGCGGGGCGGCCGGTCACCGTCCTGGTCCGGGGCGAACCGGGAGCCGGGAAGTCCGCCCTGCTGGAGGCGGCCGCCGGGCTCGCCGCCGCCGCGGGCTTCCACGTGGCCGTGGGCGACGCGCGCGGCCTGCCCGACAGACCGTTCGCCGCCGCGGGCTGCCTGCTCGACCGGTTACCCGGCCCGGGGGATCAGGACCGGGCGCAGGCCCCCGCCCCCGGTGCCGACCCCCTGGGCGAACTCGTGGAACGGGCCCGGCGGCAGGCCGCCCGCGCGCCCGTGGCCCTGTGCCTGGACGACGCGTCCCGGTTGGACACCGGGTCGCTGCGCTGGTTACTCGCCCTGTCCCGGAGCATGCCGCCGGCCCGGCTGGCGATCGTGCTGGCGGCCCGGGACCTGGCCACGGCCCCCGGAGCCGAATTCGCCGTCGCAGCGGAGGTCCTCGACCTCACCGGCCTGCCGGCCGACGCCGTCACCCCCTTCGCCGAGACCCGCTGCGGGGTCTCCCTCGACGCGGCGGCCGCCCGGGCCTGTCACGAACTGACCGGCGGCAACCCGGCGTTGCTGCTGGCCCTGCTGGCCGGACGATCGGGATCCGCGCCCGCCCCCGACGACCTGCGCCCCGCCCCCGGCGCCGCCGCGCTCCCCGGAGCCGAGCGCTGGCTCGGCGGACTCACCCGCCCGGCCCTCGAACTGGCCCGGGCCGTCGCCGTCCTCGGCGCCGACGCCGAGATCACCCAGGCCGCCCGGCTCGCCGGCCTCGACGTCGGGGAAACGCTGCCGGCCGTCGACGAACTGGTCGGCCGATGTCTGCTCGCCAACCGCACCCCCCTGACCTTCCGGCATCCGCTGCTCGCGACCATGGTCACCGAGCGGATCCCCGCCGGCACCCGGGCCGCCCTGCACCTGCGGGCGGCCGAACTGTTGCGGGACGGCGGTTTCGGCGCCACCCGGGTGGCCCGGCACCTCGTCGCGGCGGGACCGCTCGGCCTGAGCTGGACCGTCGAACCCCTGATGACGGCCGCCCGCCGACTGGCCGGCGAGGGCAGGACGGAGGAGGCGGCCCAGCACCTCCGCGGCCTGCTCCGCGAACGGCTGCGCCCCCGCGTGCGGGCGGCCGTCCGCTGTGAACTCGCCCGGCTGGACGGGTTCGTGAACCCCGACCGCGCCATCCGGCTGCTGGACGCCGCCCGGCGCGAGGCCGAGGACCCCGCGGTCGCCACCGACTACGCCCTCGACCTGGCCGCGCTGCTGGCCGGCTGCGGCAGACCGGTGGACGCGGTGGCCGTCCTCGACGACACGGCCGACCGGATCGGCCCGGCCGCGCCCGGGCAGCTCCGGAGACTGCGGCTGCACCGCGCGCTCGTCCGCGTGGCCGGTCCGGCCCGGCTGTTCCCGGAACGCGAACGGCCCGACGGCGCGCCCGCCGACGAGGCCGGGACCGCCGGAGCCGTGGATCCCCCGGACGCCCCGGAATCACCGCACTCACCGCACTCACCGGACGTCCCGGACTCCCCGGACACCGCCGGCCGGCCCGCCGCCCTGCGCGCCGTACACGCCGTCCGCGCCGGCGAGGACCGTGCGGGCGCCGTCCGGTACGCCCGCGAGGCGCTGGCCGCCGGCGGGGACGGCGGCACGGCCACCGTCCTCTGGTACGGCTGCCGCACCCTGATCCACGCCGACGAACTGACCGAGGCGGCGACCTGGTGCGGGCGCTACCGGCCGGTCCGCGGGGCCCGGCCGGGGCGGTGGACGGACGTCGCCGTGGACCTGCTCCGGGCCACGGTCCGCCGGGTCCGCGGCGACCTGCCGGGCGTGATCGAGATGCTGGCGCCCCTGACCGAGCCGCTGTGTACGGAGCCGGGCGCGTCGCACGTGCTCGCCCGGCTCGCCGTCGCCGCCCTGATCGAGGCCGGCGCCATGGCCGGCGACACGGACACCGCGCGGACGCTGCTGACCCGGTGGGGGCTGGACGGCGAACAGCGGCCCCGGCAGGACACGGTGGGGGTGCTGGCCGCCCGCGCCGTCCTCCGGTCGCGGACCGGCGAGGTGCCGGGCGCGGTGGAGGACTGGTACACGGCCGGCCGGATGCTCACCGAACTCGGCGTGCGCAACCCGGCGGTCCTGCCCTGGCGGTCCCGGGCGGCCCACCTGCTGGCCGCCGAAGGGGAGACCGCCGAGGCCGCCCGCCTGGCCCGCGCCGAACTGGAGGACGCCCACCGCTGGGGCACGCCCCGGGCCGTGGGCACGGCCCTGCACGCCGTCGCGATGACGGAGACCGGGCCGCGCCGGATCGAACTCCTCGACAGCGCCGTCGCCCTGCTCGGCCGCTCGCCCGCCCGGCTCGGCGTCGCGGCGGCCCGGCTCGACCTCGGACGCGCCCTCGGCGCCGCCGGCCGTGCGGAGGAGGCGTGCGACGCGTTCACAGCCGCGTCCGCCGGAGCCGAGAGCTGCGGCGCCCGTCCCCTGGCCCGGCGGATCGCGGCGGCGCGCCGGGAGATGTGCCCGACGGAGGAGCGTGAGACCCTGCCGGCGACCCTGACCGGCCTGACCCCGCAGGAACTCCGCATCCTCTCCCTGGCCCGCGACGGCCACACCAACCGGGAGATCGCCGGCCGGCTCTTCGTCACCCTCCGGACCGTGGAGTTCCACCTCTCCGGCGCCTACCGCAAACTCGGCATCTCGGGCCGCCGCCAGCTCGCCGAGGTCATGCCGGCGGAGTCCCGGACGCCCGCGTGA	MASVGATGRGSELARLAGLFDEARAGRPVTVLVRGEPGAGKSALLEAAAGLAAAAGFHVAVGDARGLPDRPFAAAGCLLDRLPGPGDQDRAQAPAPGADPLGELVERARRQAARAPVALCLDDASRLDTGSLRWLLALSRSMPPARLAIVLAARDLATAPGAEFAVAAEVLDLTGLPADAVTPFAETRCGVSLDAAAARACHELTGGNPALLLALLAGRSGSAPAPDDLRPAPGAAALPGAERWLGGLTRPALELARAVAVLGADAEITQAARLAGLDVGETLPAVDELVGRCLLANRTPLTFRHPLLATMVTERIPAGTRAALHLRAAELLRDGGFGATRVARHLVAAGPLGLSWTVEPLMTAARRLAGEGRTEEAAQHLRGLLRERLRPRVRAAVRCELARLDGFVNPDRAIRLLDAARREAEDPAVATDYALDLAALLAGCGRPVDAVAVLDDTADRIGPAAPGQLRRLRLHRALVRVAGPARLFPERERPDGAPADEAGTAGAVDPPDAPESPHSPHSPDVPDSPDTAGRPAALRAVHAVRAGEDRAGAVRYAREALAAGGDGGTATVLWYGCRTLIHADELTEAATWCGRYRPVRGARPGRWTDVAVDLLRATVRRVRGDLPGVIEMLAPLTEPLCTEPGASHVLARLAVAALIEAGAMAGDTDTARTLLTRWGLDGEQRPRQDTVGVLAARAVLRSRTGEVPGAVEDWYTAGRMLTELGVRNPAVLPWRSRAAHLLAAEGETAEAARLARAELEDAHRWGTPRAVGTALHAVAMTETGPRRIELLDSAVALLGRSPARLGVAAARLDLGRALGAAGRAEEACDAFTAASAGAESCGARPLARRIAAARREMCPTEERETLPATLTGLTPQELRILSLARDGHTNREIAGRLFVTLRTVEFHLSGAYRKLGISGRRQLAEVMPAESRTPA	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	BGC0001145.1|Cyclothiazomycin_10#12919#15726#-1#ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.786	gnl|BL_ORD_ID|621|hsp_num:0	1015
BGC0001145.1|Cyclothiazomycin_5	ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.773	6263	8860	+	Loose	n/a	8.372	OXA-349	36.36	ARO:3001536, ARO:3002819	OXA-349, msrC	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of beta-lactam resistance	antibiotic inactivation enzyme; determinant of beta-lactam resistance; efflux pump complex or subunit conferring antibiotic resistance	950	25.409	25.409, 25.7942	ATGGACCCGGACTTCTCGACCCCGGACACCTTCGGCGTGCGCGTCGGCGGGCTCCCGGTGGCGGCGCTGGACGCGATGCGCTCCCCCGCGCTGTGGGAGCGGGTGGAGGCGGTGCTCGACGGCGACGAGCGGCTCGCCGCGCGGGCGGCGGAGCTGTCGGACGCCCTCTTCGCGGCGATCGGGCGGACGGCGGAGGGCCGGCCGGCGCTGGTCGCCCTGCGCCGCGCCGTGCACAACCGGAAGCCGCTCACCGACCGGTGCTGGAACGACTCCGTCCGCGCCCTGCTGCCGGCCGCCGTCACCGAGGGCGTCCACGCCTGGCTGCGGCTCCGCGAGGAGCACGAGCGGGACCGGGCGCGCCTCGCCGAGCAGGTGGAGCACCACGCCCGCACCCGGCACGTCCCACTCCGGAAGGCCGTGAGCGACCCGGCGTTCCGGCACGGTCTGGTGCTGAGCAGCCCGGATCTCCACGCCGACGTGTGCCGGTGGCTGGCCCGGCCGGAGGAGACGGTCCCGGACCGCCGGCTGGCGCTGCGGCTGACCAAGTACCTCTCCCGCGTCGCCCTCAAGACCACCCCGTTCAGCACGTTCACCGTCAGCGGTCTGGGGACCTGGCGGGACGGGCCGGTGGCCGGGCCCCCGGCCCCGCCCGCGGTGCGGACCGTGGCGGAGGTCAACATCTGGGTGGTGCAGCAGTTCGTCCGGGAGCTGTCCCGGCATCCGGCGCTGGCGCCCGGGGTCCGGCTGCGGCTCAGCCCGGCCGCGCTGCGCACCGGCGACCGGTGGGAGTTCCTCGGTCCCGGGCCCGAGGAACCGCTGCGCGGCCTGGCCGCCTCCCCGCCGGTCCGGGCGTGCGTGGACGCGGTGGCCGGCGGACGGACGCGGGCGGAGGCGGCCCGGCGGGTCGCGGAGCTGACCGGCGGCACCCCGGAGGCGGCCACCGCCTACCTGGACAAGCTGGTCGAGCTGGGGCTGCTGGAGGCCGAACGGCCCTTCCCCGACCAGGATCCCGATCCGCTGGGGGCGCTCCACGCGTGGGTGTCCGGCGCCGGCCTCTCCGACCTCGGCGCCGAAATCGCCTCCCTCGCGGCGCGGTTGGACGCGTACCCGACGCTCACCGATCCGGCGGACCGGCTCGCGAGCGTCCGGGGCGTCGAGTCGGCGCTGGGCCGCGTCGCGGCCCTCGTCGGCCCGGAGCGGGTGGCGCTGCCCGGCAAGAACAGCGTCGTCGAGAACGCCCTGCTCGTGCCCCCGTCCACCGCCCTCGACCGCCGGGCCTGGGACCCGGTGCTCCGCGACCTGGACGTCGTCCGCCGGCTGCACGGCGTGCTGGACCCCGCGCAGCCGGGCCGGATCGCGCTGGCCGACCTCGTCGCCGAGCGCGTCGGGCCCGGGGCCGCGATGCCGTTCCTGGCCTTCCACCGGACGGTGCAGGGCTGGGTGCGCGAGGATCCCGGCCTGCTGGACGTCCTGTCCGTCACCACGCACGGCTACCGCGCCCTGTCCGGCCACCGGCTGCCGCGCCTCAGGGAACTGGCCCGGCTGCGCGCCGAGTTGTGCGCGGAGGCGCTGGACGGACGGCCGGACGCGGGCGGCGTCCTGCGGCTCGACCCCGGCCCGCTCGCCGCGCGCGCCGCCCGCTGGCCGCACTGGCTGCGCCCGCCGGACTCCGTGACGTACTACGGCCAGCCGCTCGGCGACCCGGCGGACCCCGGCTTCGTCGTCAACGCCGTCAACTCCGGCCACGGGCGCGGGCGCGACCGGATCCGGCGGCTGCTCGCCCAGGCCGGGACCGCCGCGGACGCGCACACCGCGCCGCCGCCCGACGGCGTCCTCGTCGCGGACACCTGCCGGCACTACGGGAGCAACGTGGGGCTGCGGTGTTCGGCGGTGGCCGACGAGATCGACGTCCCCGGCGGCTGGAGCCGCCGCCCGGCGGAGCACCGGATCCCGCTGGGCGACCTGGAGGTGCGGCACGACCCGGAGGCGGGTCTGCTCGTGCTCCGCTCCCTGGCGCGCGGTGTCGAGGTGCGGCCCGTGCACCCCAACCTCATCGCGGAGATGTGGCTGCCGCCCGCCGTCCGGCTGCTCCTGCAGGTGTTCGGCGCGACGTCCAACCTGCTGATCCCCGGCCGGCGGATGTTCGGCGACACCTCGCCGTCCCTGGTGCGGGAGTTGCGGTCCGAGCCGCGGGTGGTGGTCGGGCGGACGGTGGTGAGCCGCCGCCAGTGGGTGTTCCCCGCCGGTGCCGCGCCGGCGCGGCGGCCCGGCGAGGGCGACGCGGCGTACCTGACGCGCCTGGCCGGCTGGCTGCGCGCGCACGGCATGCCGCGGCGCTGCTTCGTCCGGGCCCTGGACCCCGGCGCGGTGGCCGACGGCAGTGTGTGGCGGGTCAAGTCCCGCAAGCCGCTGGCCGTGGACTTCGCCAACCTCCTGCTGGTCGGCCTGTTCGAGCGGATGCTCGCCGAGCCGGACCACGTCCTGTTCCTCCAGGAGGCGCTGCCCGACGCGTCCGGCCTGCCGGACCACGGTGACGGCGCGCCCCGGGTGACCGAATACCTCATCGAGATCAACGGAGGCCGGCATGCCGACCGCTAG	MDPDFSTPDTFGVRVGGLPVAALDAMRSPALWERVEAVLDGDERLAARAAELSDALFAAIGRTAEGRPALVALRRAVHNRKPLTDRCWNDSVRALLPAAVTEGVHAWLRLREEHERDRARLAEQVEHHARTRHVPLRKAVSDPAFRHGLVLSSPDLHADVCRWLARPEETVPDRRLALRLTKYLSRVALKTTPFSTFTVSGLGTWRDGPVAGPPAPPAVRTVAEVNIWVVQQFVRELSRHPALAPGVRLRLSPAALRTGDRWEFLGPGPEEPLRGLAASPPVRACVDAVAGGRTRAEAARRVAELTGGTPEAATAYLDKLVELGLLEAERPFPDQDPDPLGALHAWVSGAGLSDLGAEIASLAARLDAYPTLTDPADRLASVRGVESALGRVAALVGPERVALPGKNSVVENALLVPPSTALDRRAWDPVLRDLDVVRRLHGVLDPAQPGRIALADLVAERVGPGAAMPFLAFHRTVQGWVREDPGLLDVLSVTTHGYRALSGHRLPRLRELARLRAELCAEALDGRPDAGGVLRLDPGPLAARAARWPHWLRPPDSVTYYGQPLGDPADPGFVVNAVNSGHGRGRDRIRRLLAQAGTAADAHTAPPPDGVLVADTCRHYGSNVGLRCSAVADEIDVPGGWSRRPAEHRIPLGDLEVRHDPEAGLLVLRSLARGVEVRPVHPNLIAEMWLPPAVRLLLQVFGATSNLLIPGRRMFGDTSPSLVRELRSEPRVVVGRTVVSRRQWVFPAGAAPARRPGEGDAAYLTRLAGWLRAHGMPRRCFVRALDPGAVADGSVWRVKSRKPLAVDFANLLLVGLFERMLAEPDHVLFLQEALPDASGLPDHGDGAPRVTEYLIEINGGRHADR	MYKKALIAATSILFLSSCSSNTVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQTEEIYGNDLKRAPTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRVGFGNASIGSKVDNFWLVGPLKITPQQETQFAYQLALKTLPFSQDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWIVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL	BGC0001145.1|Cyclothiazomycin_5#6264#8861#1#ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.773	gnl|BL_ORD_ID|1559|hsp_num:0	646
BGC0001145.1|Cyclothiazomycin_1	ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.785	0	1910	+	Loose	n/a	1.56436	mphE	30.77	ARO:3003992, ARO:3001780, ARO:3001765, ARO:3001767, ARO:3003071	rphB, OXA-136, OXA-85, OXA-137, mphE	protein homolog model	n/a	determinant of macrolide resistance; antibiotic inactivation enzyme	antibiotic inactivation enzyme; determinant of beta-lactam resistance; determinant of macrolide resistance; determinant of rifamycin resistance	500	27.7202	26.5646, 28.4906, 26.1794, 26.1794, 27.7202	ATGCTACCGAAACTGAAGTCCGACGTGCTGTACGTGCCCACTCCCGACGGCGCCCACGTCTTCGGGGCGGGCGCCGACGTCGCGCTGCGCGGGCCGGCCGCCTACCGGCTGCTGGACCGGCTCGCACCGCACCTGGACGGCTCGACCGAACTCGACGCGCTCGTCCGCGGTCTGCCGGACGGCACCCGCACCGCCGTGGAACGGCTGGTCGGACGGCTGCAGTCGGCCGGCTGCCTCATCGACGCGGCCGCGGACCTGCCGCACGGTCTGACCGCCCGGGAACTCGACACGTATGCGGCCGAGATCGCCTTCGTCGAGTACCACGCCACCTCGGCGGCCCGCCGGTTCCAGACCTACCGGGACAGCGCGGTGACGGTGGTCGGCGCGGGACCGGTGTTCACCGCCCTGGTCTGCTCGGCGCTCCGCTCGGGCGTGCGGCGGCTGCGGGCCGTCCACACGCCGGACACGGGCACGGATCCCGCCGCCGACGCGGACCGGCTGACCGAACTGGCCGCCGAGGCGGCGCTCCGCGACCCGGACCAGACGCTGGAGCGGGTGCCGTTCTCGGCGGCGGAGGAGGACCGGCTGGCGACCGCCGACGCGGTGCTGCACGTGGCGGCGGGCCCGGCGGTCGAACGGGCGCCGCGGCTGGACCGGTTGTGCGGCACCTCGGGCACCCTGCTGGTACAGGGCGTGGTGCTCGACGACGTGGCCTGGCTGGGGCCGCCCGGGCCGGACTGGGCGTCGGCCTGGTCGCGGCTGCGCGCCCGGCCGCCGTACCGGACGGGTACGTTCCTGACCGGGCCCGCGGCGGCGGTGGTCGCCGGGCACCTCGGGCTCGCCGCCTTCCGCGCGCTGGCCGGCATCGAGGAGCCGGGCGCGCGGGCCGCGCTGACCCGGATCGACCTCGAGACCCTGCGCACCTCGACGCACGCCTTCCTGCCGCACCCGGCCGCGCGGCCGGCCGGACCGGAGCCGGCGGCGGCGTTCACGGCCCGGATCGGCCGGCTGCGCGCGGCGGCGCCCCTGAGCGCGGAGGAGTTCTCCGCCGCCGCGGCGGCCTGCTTCGACCCGTACACCGGTGTCCTGCGGACCCTGGACGAGGGGGACTTCACCCAGATCCCGCTGCACGTCACCGAAGCGGTCCCGCACCTCGCCGACTCCGGCGGTCCCCGGGTCTTCGGCACGGGACCGGACTTCGCCGAGGCCAGGCGGCGGGCGGCGCTCCGGGGGATCGCCCGGCACGCGGCGGCCTCGCCCGACCCGCGCCGGTTCGGCCCCGGCGCCACGGTGTGGGGCTGGGACCTCGCCGACGGGCAGCCGGTGCGGGTCCCCGCGGACACGGCGTTCTCGGCGGGCACCGGCCTGGCGGCGCGGCTGTCCTGGGACGAGGCGGTGGACGACGGCCTCGGGCAGCACTGCGCCCGGCTGGCGGCCGAGGACGTGGCGGCGGGCCGGACGCGCCCCGTCCCGCTGGACCTCACCCAGGCACCGGCCGACGAGCGGACCGCACGGTACCTCGGCCTGCTGCGGGCCGCCGGCGGCACCGCGCGGGTCGCGGACATCGGTGGCGCGCTCGGTGTACCGGTCCTCGCCTGGTGGCTCGACGGCCGCCCGGTCGCGGTGACCTGCGGCCCGGACGCGGCGGCGGAGGGCCTGGAACGGACCCTGCTGGCGCGCCAGTCGGCGATGACCGACGAGCCGGCGTACGCGCCGGAGCCGGTCCCCGGCCTCGGCGACCCACCGGAACCGGCCCCGACCGCCGCCTGGCCGGCCGCACCGGACCGCGCCGCCCTGCCGGCCGCCCTGCGCTCCCGCGGCCTGCGCCCCGTGGCGGTCCCCTTGGACCACGACCCCGCCGTCCACGACGTCCTCCCGTCCGTGCTCCGGGTCGTGACGGCCGATGCGTGA	MLPKLKSDVLYVPTPDGAHVFGAGADVALRGPAAYRLLDRLAPHLDGSTELDALVRGLPDGTRTAVERLVGRLQSAGCLIDAAADLPHGLTARELDTYAAEIAFVEYHATSAARRFQTYRDSAVTVVGAGPVFTALVCSALRSGVRRLRAVHTPDTGTDPAADADRLTELAAEAALRDPDQTLERVPFSAAEEDRLATADAVLHVAAGPAVERAPRLDRLCGTSGTLLVQGVVLDDVAWLGPPGPDWASAWSRLRARPPYRTGTFLTGPAAAVVAGHLGLAAFRALAGIEEPGARAALTRIDLETLRTSTHAFLPHPAARPAGPEPAAAFTARIGRLRAAAPLSAEEFSAAAAACFDPYTGVLRTLDEGDFTQIPLHVTEAVPHLADSGGPRVFGTGPDFAEARRRAALRGIARHAAASPDPRRFGPGATVWGWDLADGQPVRVPADTAFSAGTGLAARLSWDEAVDDGLGQHCARLAAEDVAAGRTRPVPLDLTQAPADERTARYLGLLRAAGGTARVADIGGALGVPVLAWWLDGRPVAVTCGPDAAAEGLERTLLARQSAMTDEPAYAPEPVPGLGDPPEPAPTAAWPAAPDRAALPAALRSRGLRPVAVPLDHDPAVHDVLPSVLRVVTADA	MRGTGQTAGMTETSPSSPSSATADAGTPPPADLEQLLALAADHGLDLLGDSLRTEEIGLDFRVAFARSRDWQDWVLRIPRRAEVLARAAVEGRLLAHLAPHLDIAIPDWRISTERLIAYPLLPGTPGLTVSADGTVEWHVDMASTEYARALGTFLAQLHTVDPEEAAATGIPSRTPSEVRGVWREDLTRVAEAFPIAPALRERWEAWLAEDSYWPDRSVLTHGEVYPGHTLVEGERLSAVLDWTTASVGDPARDLMFHRSSAPPEAFAATLAAYVAGGGTLHPRLGEHAEEMFSASPLAYGLYALETGEEEHRAAAAAALDPPDAD	BGC0001145.1|Cyclothiazomycin_1#1#1911#1#ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.785	gnl|BL_ORD_ID|1662|hsp_num:0	473
BGC0001145.1|Cyclothiazomycin_2	ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.790	1903	3834	+	Loose	n/a	3.48513	KPC-17	39.66	ARO:3002320, ARO:3002325, ARO:3002324, ARO:3002329, ARO:3002317, ARO:3002327, ARO:3002318, ARO:3002313, ARO:3003049, ARO:3002321, ARO:3002322, ARO:3002314, ARO:3002315, ARO:3002312, ARO:3002316, ARO:3003180, ARO:3002323	KPC-14, KPC-15, KPC-17, KPC-10, KPC-7, KPC-12, KPC-3, KPC-2, KPC-8, KPC-5, KPC-13, KPC-19, rosB, KPC-6, KPC-22, KPC-4, KPC-11	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of beta-lactam resistance	antibiotic inactivation enzyme; determinant of beta-lactam resistance; efflux pump complex or subunit conferring antibiotic resistance	550	26.5646	25.0238, 25.0238, 25.0238, 25.0238, 25.0238, 26.5646, 25.0238, 25.0238, 26.1794, 25.0238, 25.0238, 25.0238, 25.0238, 25.0238, 25.0238, 26.1794, 25.0238	ATGCGTGACCACGTGCCGGGGACACCGGGGACCGGCGGGGGCGGAGAGAGCGAACGGGCCGGTGCCGCCGCGGGAACGCACTCCGCCGGGCCGCGCCCGCCGACGCCCGGCACCCTCCGGCCCCGACCGGGCACCCCGCCGGCCCGCACCTCGGCCTTTCCGCCGGACGGCCCGGCACCCGTCCGGCCGGAACCCGCGGGGGAGCACGGTCCGTCGGCGGCGGGCGTCCCCGCGGATCCGCCCCCGGGCGCCCCGCCCGGCACCCGGCCGGACGGCCTCGTCCTCCACCCCGCGCATCCGGAAGGCGCGCCTCGCCCCGGTCCGGCGGCCGTTCCGCCCGAGAGCGAGCCCGGCACTCCCGGCCTCCGCTTCTGGTGGCGCACCTTCGAGGGGGTGCGGGAGCTGTTCGCGGAGGGGCAGGGGGCCGAGGGCGGGGACGGGGATCCGCTGCCCGTGAAGACGTACCGCGGGCTGCCGCGGCACGTGCTGAGCCCGCCGGCGCGGCGGATCGGGGACGCGCGGTGGTCCTTCGAGGGCTTCCGCCGGAGCCGGCCCGACGGCGTCCCGGGCCGGGCCGCGCTGGACGAACCGGCCGTGTCCGCCCTGACGCACCACACGTACGGGCTGGCCCGGATCGAGCTGGGGCCGCACGCGTCGTGGCCGTACCACCGCGTCGTCCCGTCCGCCCGCTGCTTCCACCCGGTGGAGCTGTACCTGTGGCTCGCGGCGCCGGCCGGGGAACTGCCCGCCGGCTGCTACCACTTCGATCCCGCGCACCACGCGCTGACCCGGCTGCGCACCGGCGGGATCCCGGCCGCGCTGCACGCCGCCGCGGGCACCGGGCGGGCCGGGGGCGGCACGCTGGCGCTGCTGGTGGCGGCCGTCCACTTCCGTAAGACGGCGTTCCGCTACCGCGACTACGCGTACCGGCTGGGCGCCCAGGAAGCGGGCATGACCGTCGGCAACGCCCTGATGGTCGCGGCGGCGCTGGGCCTGGAGGGGAGGGTCCACCAGCGGTTCGGGGACGCCGTGGTCGACCGGGCGCTGGGCCTGGACGGTACGGAGGAGACCGCGTTCGCCGTGGTCGACCTGTACGGCGCGGCGGGCGGGCCTCCGCCGGGGGCCGGTGTGCCCGAGGCGCCGTTGGGCGTCATCCGGCCGGAGTACGTGCGCACGTGCCACGCCGACGCGGCGGCCTGGTCGGGGCTGACGGCGCTGGACCGCGCGGCCCGGCTGTCCGGTCCGGGCGCCGCGCTGGACACGTCCGCCTTCCACGCGCCGCAGGCCGCCTCCGAGGCCGCGGCCCTGCCCTTGGGCGGCGCGGCGCCCGGCCGGCGGGAGCTGGCGGAGGCGCTGCGCGCCCGGGACTCGGGCGGGCGGATGTTCCTGCCGGCCGACGCCGAGCTGCCCGCCGCCGCCCTGGCGGGGCCGCTGCGGCACGCGCTGGAGCCGGTTCCGTCGGACCACACCGGAGGGCCCCGCCGGCCGCTGGTGGACTGCCACGTCCTCGTCCGGAACGTGGCGGGGGTGCCCGCCGGGCTCTACGGGCTGGACCCCGGGCCCGCGCCCTCCCTGGTCCCGCTCCCCCACCGTGACGGCTCCGCCGTCGTGGCGATGGTCTGCGACCGGACGCCGTCCGTGAACGCGGCCAAGGCCAACGCCCTGGTCTTCCTGACGGTGGACCGGGAGGCGGGCGACCGTGTCCTCGGCCCGCGCGGGTACCGGATCCTGCACCAGGAGGCGGGCGTGGTGGCGCAGCGGATCAGTGTGCTGGCCGCGGCGGAGGGGGTGTCCGCGCGGATCACCAACGGGTACGACGACCGGATGGTCCGCGAGTTGCTCGGCGCCGGCCCGGAGCGGGTGCCCGTCTTCGCCCTCGTCCTCGGCCGCCGCCGGCCCACGGCCCAGTACGAACCGCCGCTGACCTGGTGA	MRDHVPGTPGTGGGGESERAGAAAGTHSAGPRPPTPGTLRPRPGTPPARTSAFPPDGPAPVRPEPAGEHGPSAAGVPADPPPGAPPGTRPDGLVLHPAHPEGAPRPGPAAVPPESEPGTPGLRFWWRTFEGVRELFAEGQGAEGGDGDPLPVKTYRGLPRHVLSPPARRIGDARWSFEGFRRSRPDGVPGRAALDEPAVSALTHHTYGLARIELGPHASWPYHRVVPSARCFHPVELYLWLAAPAGELPAGCYHFDPAHHALTRLRTGGIPAALHAAAGTGRAGGGTLALLVAAVHFRKTAFRYRDYAYRLGAQEAGMTVGNALMVAAALGLEGRVHQRFGDAVVDRALGLDGTEETAFAVVDLYGAAGGPPPGAGVPEAPLGVIRPEYVRTCHADAAAWSGLTALDRAARLSGPGAALDTSAFHAPQAASEAAALPLGGAAPGRRELAEALRARDSGGRMFLPADAELPAAALAGPLRHALEPVPSDHTGGPRRPLVDCHVLVRNVAGVPAGLYGLDPGPAPSLVPLPHRDGSAVVAMVCDRTPSVNAAKANALVFLTVDREAGDRVLGPRGYRILHQEAGVVAQRISVLAAAEGVSARITNGYDDRMVRELLGAGPERVPVFALVLGRRRPTAQYEPPLTW	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQLVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ	BGC0001145.1|Cyclothiazomycin_2#1904#3835#1#ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.790	gnl|BL_ORD_ID|62|hsp_num:0	2038
BGC0001145.1|Cyclothiazomycin_4	ID=1_4;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.773	4304	6247	+	Loose	n/a	1.6202	APH(3')-IX	44.44	ARO:3004087, ARO:3003576, ARO:3002561, ARO:3002914	PmrC, APH(3')-IX, vanJ, AAC(6')-Ir	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of aminoglycoside resistance	antibiotic inactivation enzyme; determinant of aminoglycoside resistance; determinant of polymyxin resistance; determinant of resistance to glycopeptide antibiotics; gene altering cell wall charge; protein(s) conferring antibiotic resistance via molecular bypass	600	27.335	27.335, 26.1794, 25.409, 27.7202	GTGACCGACGCCGCTCCGGACGCGCCCCCTCCGGCGGGTGCCGCCGTGCTGGGCAAGGGCCTGCTCGCCACCGCCGTCCGCACCGCCCTCGGCCGCGCCGGCCTCCTGGTCCCCGAGCCGGGCACCGGCCGCTCCGCCGTGGTGACCGTGGACGACGGGTGGAACCCGGCGACGGAACCTGAGGTTCCGGGCGTCCCGTGGCTCCCCGTCCGGGTCGAGCTCGGGACCGTCGTCATCGGGCCGTACGTCGTCCCCGGCCGCCCCGGCTGCGCCCGCTGCGCCCGGACCCGGCGGACCCGCGCCCTCGGCCCGGACAGCCCCCGCGCGGAGCTGGTGCGCCGCCACGGGGACCGGCTGGCCGACCGGGACACGCCGTTGCTGCCCGCGCCGGCGCGCGACACGGTGGCCGCCCTCGTCACCCATGAACTGACCTCCGGCGAACACCGGTTGACCGACCGGGCCGTCCTCATGCTCGCGCTGCCCGCCCTGACGGCCGGCGTCCACCCCTTCCTGCCCGTGCCCGACTGCCCGTCCTGCGGCGGGCTGCCCCCGGACCGGCCGCCCGTCCTCATGGACGTACCGCGCCCCAAGCCGGCCCCGGACGTCCACCGGACCCGCGACCTCGCGGCCGGCTGGGACGCGCTGCGGGACACCTTCGTGGACGGCCGCACCGGCGTGGTGCGCCAGCTCGACGTGCGGACGGACTACCCGTACCCGATGGTGTCGGCCCCCCTCCACCTGCCCGGCGGCGAGCAGGAGGCGGGGTTCGGCCGCGACCTGGACTACGCGTCCTGTGCCCGGACGGCCCTGGCGGAGGCCCTGGAGCGGCTCGGTGGGGCCCGCCCCGGCGGCCGGCGCCCGACCGTACGGGCCCCCTACCGCGACGTCGCCGGACACGCGCTGCACCCGCCGGACCTCGGCCTCTACCCGCCGGAGCGGTACGCGGAACCCGGCTTCCCCTACCCGCCGTTCGACCCCGGCCTCGAACTCTCCTGGGTATGGGGGCACTCCTTCGCCCGCGACGCGCCCGTCCTCGTCCCCGAGGACTACGCCTACTACCGCACCCGGCACGACGGCCCGCACGCCCGGCCGCTGGCCTACGAGGTGTCCAACGGCTGCGCCCTGGGCGGCTGCCTGGAGGAGGCGGCCCTGCACGGGCTGGTGGAGCTGGCGGAGCGGGACGCGTTCCTGCTCACCTGGTACGCCCGGCTGCCCGTCCCCCGGATCGACCTCGGCACCGTGTCCGACCCGCGGATCCCGGTGCTGGCCGAGCGGATCCGGCAGGACGGCGGCCACCGGGTCGTGGCCTTCGCGACCACGCCCGACCACGGCGTCCCCAGCGTCTGGGTGATGGCCGTGCACCCCCGTCCCGGCCGCGAGCCGGCGGCGGTCTGCGCGGCCGGCGCCCACTTCGATCCCGAACGGGCGCTGCTCAACGGCCTGCTGGAGCTCACCGCGAACCTCGGCTGGAACCGGGTGGCGTGGCGCGAGGAGACGGCCCGGATCGCCGCGATGGTCGACGACCCGGAGCTGGTACGGGAGATGCGCGACCACGCGCTGCTCTACTGCCACCCCGCCGCCTTCGACCGCTTCGGCTTCCTGTTCGGCGACGCGCCCGCGCTGCCGGTGCGGGAGGCGTTCGCGCGGGCCGGCCTCCGGCCGCGCGGGGACGACCTCCGCGACGACCTGGCCGAGGTGGTGGCCCGGTTCACCGGCGCCGGACTCGACGTCGTCGTGGTGGACCAGACGACCGACGAGCACCGGGCGGGCGGTTTCGCCTGCGCCAAGGTGATCGTGCCGGGACTGCTGCCGATGACCTTCGGCCACCGGATGCGCCGCACCCACGGCCTGCCGCGCCTCCGCGACCTGCCGGCCCGCCTCGGCCACCGCGCCGGACCGCTGGGCCCGGACGACGTCAATCCGCACCCCCACCCGTTCCCCTGA	VTDAAPDAPPPAGAAVLGKGLLATAVRTALGRAGLLVPEPGTGRSAVVTVDDGWNPATEPEVPGVPWLPVRVELGTVVIGPYVVPGRPGCARCARTRRTRALGPDSPRAELVRRHGDRLADRDTPLLPAPARDTVAALVTHELTSGEHRLTDRAVLMLALPALTAGVHPFLPVPDCPSCGGLPPDRPPVLMDVPRPKPAPDVHRTRDLAAGWDALRDTFVDGRTGVVRQLDVRTDYPYPMVSAPLHLPGGEQEAGFGRDLDYASCARTALAEALERLGGARPGGRRPTVRAPYRDVAGHALHPPDLGLYPPERYAEPGFPYPPFDPGLELSWVWGHSFARDAPVLVPEDYAYYRTRHDGPHARPLAYEVSNGCALGGCLEEAALHGLVELAERDAFLLTWYARLPVPRIDLGTVSDPRIPVLAERIRQDGGHRVVAFATTPDHGVPSVWVMAVHPRPGREPAAVCAAGAHFDPERALLNGLLELTANLGWNRVAWREETARIAAMVDDPELVREMRDHALLYCHPAAFDRFGFLFGDAPALPVREAFARAGLRPRGDDLRDDLAEVVARFTGAGLDVVVVDQTTDEHRAGGFACAKVIVPGLLPMTFGHRMRRTHGLPRLRDLPARLGHRAGPLGPDDVNPHPHPFP	MINDMKISLPQSLKSFIGNQPLQKDKVGQSPSDVYSFTKNNEKYYLKTTELIYAQTTYSIIREAKILDWLDGKLNVPELVLMDTDHENEYMISKAVPAKPLQDFTGKSDQFFIDIYTDALAQLQSISIKNCPFISNKKFRLAEAEFFIENGLLDELDDDEKDLKLWSSYQNFAEFLDDLKQQNFQEEYVFSHGDLTDSNVFLSHDAQIYFLDVGRAGIADRFVDIAFIERSLREDCSEDAALQFLNHLAEDDSFKRNYFLKLDELN	BGC0001145.1|Cyclothiazomycin_4#4305#6248#1#ID=1_4;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.773	gnl|BL_ORD_ID|1488|hsp_num:0	2751
BGC0001145.1|Cyclothiazomycin_9	ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.718	12061	12606	-	Loose	n/a	0.020168	MexL	24.64	ARO:3003710, ARO:3004073, ARO:3000582, ARO:3001313	L1 beta-lactamase, MexL, facT, MuxA	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	antibiotic inactivation enzyme; determinant of beta-lactam resistance; determinant of elfamycin resistance; efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	1050	30.8018	30.8018, 23.0978, 24.6386, 26.9498	ATGAAGCACCAACGACAGGGCGCCGCGTCGGGCCTCGCGCGCCGTGCGGGAGTCGTGGGGGCGGCGGCGTTCATCGCCGTCGTCGGCGGCGTGTCGACGGCGGGAGCGGCGACTCCCGGCCCGGGCTCGGACCAGGTCCTCGCCAAGACGGAGTACACGTTCCACCCGGCGGGCCAGGACAGGTCCGTCGCCGCCTCGCGGCGGGTCATCCACTGCGAGATGGTCTTCGTCGGAGCCAACCACGGCGCGCCGCACCACTCCGGTCACGTGCCGGGCACGGTCAACGTCCGGGTCCGCGTGACCTGTACCCAGCCGGTGCGGCTGATCAAGGGGAAGGTCGGTCTCTTCAGCAACCACGGCTCGAAGATCAAGGAGTACGGCAGCACCGGCCGGGCCGCCGCCAAGGGCAACGCGGCCCTCGTCTGCCGGTCCGGCTACTACCAGGGCGAGTCGGCCGCCAGGATCGTCGCGCCGGTCGGCTACAACCCGCCCACCGCGGACATGGCGGCCAGGACCGCCAAGGTGCACCTGACGAAGTGCAGCTGA	MKHQRQGAASGLARRAGVVGAAAFIAVVGGVSTAGAATPGPGSDQVLAKTEYTFHPAGQDRSVAASRRVIHCEMVFVGANHGAPHHSGHVPGTVNVRVRVTCTQPVRLIKGKVGLFSNHGSKIKEYGSTGRAAAKGNAALVCRSGYYQGESAARIVAPVGYNPPTADMAARTAKVHLTKCS	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	BGC0001145.1|Cyclothiazomycin_9#12062#12607#-1#ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.718	gnl|BL_ORD_ID|519|hsp_num:0	2219
